This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Richards, E. Search for Related Content Social Bookmarking                         What's this?

The Politics of Therapeutic Evaluation: The Vitamin C and Cancer Controversy

Department of Science and Technology Studies, University of Wollongong, PO Box 1144, Wollongong, New South Wales 2500, Australia.

This paper reconstructs and analyzes the content and context of the debate over the efficacy of vitamin C in the treatment of cancer, and compares it with medical responses to, and evaluations of, two other cancer drugs — the cytotoxic drug SFU (conventionally used in the treatment of gastro-intestinal cancers) and the `naturally-occurring' (but recombinant DNA-produced) drug interferon. This comparative approach is designed to facilitate the integration of microsociological and structural levels of analysis of the processes by which knowledge claims about therapeutic efficacy are evaluated by the powerful adjudicating medical community. It is argued that the assessment of medical therapies is inherently a social and political process; that the idea of neutral appraisal is a myth; that clinical trials, no matter how rigorous their methodology, inevitably embody the professional values or commitments of the assessors; and that judgements about experimental findings may be structured by wider social interests, such as consumer choice or market forces. It is concluded that the necessarily social character of medical knowledge cannot be eliminated by methodological reform, and that this has important implications for the social implementation of medical therapies and techniques.

Social Studies of Science, Vol. 18, No. 4, 653-701 (1988)
DOI: 10.1177/030631288018004004


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. M. Will Identifying Effectiveness in ''The Old Old'': Principles and Values in the Age of Clinical Trials Science Technology Human Values, September 1, 2009; 34(5): 607 - 628. [Abstract] [PDF]

				J. Kim Alternative Medicine's Encounter with Laboratory Science: The Scientific Construction of Korean Medicine in a Global Age Social Studies of Science, December 1, 2007; 37(6): 855 - 880. [Abstract] [PDF]

				T. Schlich The Art and Science of Surgery: Innovation and Concepts of Medical Practice in Operative Fracture Care, 1960s-1970s Science Technology Human Values, January 1, 2007; 32(1): 65 - 87. [Abstract] [PDF]

				S. Chow Specialty Group Differences Over Tonsillectomy: Pediatricians versus Otolaryngologists Qual Health Res, January 1, 1998; 8(1): 61 - 75. [Abstract] [PDF]

				A. Clarke and T. Montini The Many Faces of RU486: Tales of Situated Knowledges and Technological Contestations Science Technology Human Values, January 1, 1993; 18(1): 42 - 78. [Abstract] [PDF]

				Bibliography Current Sociology, September 1, 1991; 39(2): 83 - 115.

				P. Scott, E. Richards, and B. Martin Captives of Controversy: The Myth of the Neutral Social Researcher in Contemporary Scientific Controversies Science Technology Human Values, October 1, 1990; 15(4): 474 - 494. [Abstract] [PDF]